These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 10873423)

  • 1. The antiviral 2',5'-oligoadenylate synthetase is persistently activated in type 1 diabetes.
    Bonnevie-Nielsen V; Martensen PM; Justesen J; Kyvik KO; Kristensen B; Levin K; Beck-Nielsen H; Worsaa A; Dyrberg T
    Clin Immunol; 2000 Jul; 96(1):11-8. PubMed ID: 10873423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2',5'-Oligoadenylate synthetase in autoimmune BB rats.
    Bonnevie-Nielsen V
    Prog Mol Subcell Biol; 1994; 14():198-208. PubMed ID: 8061885
    [No Abstract]   [Full Text] [Related]  

  • 3. [Alpha interferon, antiviral proteins and their value in clinical medicine].
    Chieux V; Hober D; Chehadeh W; Wattré P
    Ann Biol Clin (Paris); 1999; 57(6):659-66. PubMed ID: 10572214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of MuIFN-alpha/beta and MuIFN-gamma-induced antiviral states: differential effects with different challenge viruses and lack of correlation with 2'5' oligoadenylate synthetase levels.
    Ramamurthy V; Fleischmann WR
    J Biol Regul Homeost Agents; 1988; 2(1):7-14. PubMed ID: 2845725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired antiviral response in human hepatoma cells.
    Keskinen P; Nyqvist M; Sareneva T; Pirhonen J; Melén K; Julkunen I
    Virology; 1999 Oct; 263(2):364-75. PubMed ID: 10544109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased IFN-alpha-induced sensitivity but reduced reactivity of 2',5'-oligoadenylate synthetase (2,5AS) in trisomy 21 blood lymphocytes.
    Gerdes AM; Hørder M; Bonnevie-Nielsen V
    Clin Exp Immunol; 1993 Jul; 93(1):93-6. PubMed ID: 8324908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine pancreatic beta TC3 cells show greater 2', 5'-oligoadenylate synthetase (2'5'AS) antiviral enzyme activity and apoptosis following IFN-alpha or poly(I:C) treatment than pancreatic alpha TC3 cells.
    Li M; Zheng DJ; Field LL; Bonnevie-Nielsen V
    Exp Diabetes Res; 2009; 2009():631026. PubMed ID: 19888425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between 24-hour rhythm in antiviral effect of interferon-beta and interferon-alpha/beta receptor expression in mice.
    Takane H; Ohdo S; Baba R; Koyanagi S; Yukawa E; Higuchi S
    Jpn J Pharmacol; 2002 Dec; 90(4):304-12. PubMed ID: 12501006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of type I interferon receptor by IFN-gamma.
    Mizukoshi E; Kaneko S; Yanagi M; Ohno H; Matsushita E; Kobayashi K
    J Interferon Cytokine Res; 1999 Sep; 19(9):1019-23. PubMed ID: 10505744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-associated lymphocyte 2',5'-oligoadenylate synthetase in acute and chronic viral hepatitis.
    Heathcote J; Kim YI; Yim CK; LeBrocq J; Read SE
    Hepatology; 1989 Jan; 9(1):105-9. PubMed ID: 2461889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Basic study on human interferon-beta: Part I. Antiviral effect].
    Nobuhara M; Kanamori T; Morishita H; Horisawa Y
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2100-4. PubMed ID: 3717957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the interferon-inducible (2'-5') oligoadenylate synthetase by the Epstein-Barr virus RNA, EBER-1.
    Sharp TV; Raine DA; Gewert DR; Joshi B; Jagus R; Clemens MJ
    Virology; 1999 May; 257(2):303-13. PubMed ID: 10329541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible expression of the 2-5A synthetase/RNase L system results in inhibition of vaccinia virus replication.
    Díaz-Guerra M; Rivas C; Esteban M
    Virology; 1997 Jan; 227(1):220-8. PubMed ID: 9007077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basis for dosing time-dependent changes in the antiviral activity of interferon-alpha in mice.
    Ohdo S; Wang DS; Koyanagi S; Takane H; Inoue K; Aramaki H; Yukawa E; Higuchi S
    J Pharmacol Exp Ther; 2000 Aug; 294(2):488-93. PubMed ID: 10900223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The dynamics of 2',5'-oligoadenylate synthetase activity in the nuclear and cytoplasmic fractions of human fibroblasts treated by double-stranded RNAs, by their complexes with DEAE-dextran and by type-I recombinant interferons. The ratio of double-stranded RNA-activated and -nonactivated froms of the enzyme].
    Sokolova TM; Antonov AIu; Makhov AM
    Antibiot Khimioter; 1991 Jun; 36(6):31-5. PubMed ID: 1898186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification by electron microscopy of the maturation steps in vaccinia virus morphogenesis inhibited by the interferon-induced enzymes, protein kinase (PKR), 2-5A synthetase, and nitric oxide synthase (iNOS).
    Esteban M; Patiño C
    J Interferon Cytokine Res; 2000 Oct; 20(10):867-77. PubMed ID: 11054274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon gamma does not induce antiviral resistance in T lymphocytes.
    Zucca M; Gribaudo G; Ferrara B; Cavallo G; Landolfo S
    J Biol Regul Homeost Agents; 1988; 2(1):15-8. PubMed ID: 2845724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of IFN-alpha/beta, MxA, 2',5'-oligoadenylate synthetase, and HLA gene expression in influenza A-infected human lung epithelial cells.
    Ronni T; Matikainen S; Sareneva T; Melén K; Pirhonen J; Keskinen P; Julkunen I
    J Immunol; 1997 Mar; 158(5):2363-74. PubMed ID: 9036986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-interferon receptors in malignant B-cells from patients with chronic lymphocytic leukemia: relation to induction of 2'-5'-oligoadenylate synthetase and blast transformation.
    Ostlund L; Grandér D; Juliusson G; Robèrt KH; Lundgren E; Einhorn S
    Cancer Res; 1989 Jun; 49(12):3425-30. PubMed ID: 2524252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure to cold impairs interferon-induced antiviral defense.
    Boonarkart C; Suptawiwat O; Sakorn K; Puthavathana P; Auewarakul P
    Arch Virol; 2017 Aug; 162(8):2231-2237. PubMed ID: 28361289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.